He underwent EGD and placement of esophageal metal stent with Dr. [**Last Name (STitle) **] [**2185-7-7**] for dysphagia, his stent migrated, and he returned on [**9-8**] for Ultraflex partially covered 23x120 mm metal stent palcement his esophageal stricture (found starting at 31cm from the incisors).
CT chest showed >50% right hydropneumothorax with mild mediastinal shift and mediastinitis.
CXR showed >50% R. hydropneumothorax.
OSH CT imaging reviewed and shows R. hydropneumothorax, with pockets of air surrounding his recently placed esophageal stent.
A post chest tube placement CXR showed expansion of the right lung and improvement of the hydrothorax.
Family History: non-contributory  Physical Exam: Afebrile, vital signs stable  GEN: fatigued-appearing, otherwise NAD HEENT: OP clear, mmm CV: rrr LUNGS: clear to auscultation ABD: s/nt/nd; chest tube in place in right chest with no current appreciable drainage EXT: warm/dry, no edema NEURO: grossly intact  Pertinent Results: [**2186-9-15**] 07:50PM BLOOD WBC-14.0*# RBC-3.49* Hgb-10.6* Hct-30.9* MCV-89 MCH-30.5 MCHC-34.4 RDW-15.1 Plt Ct-322 [**2186-9-17**] 03:43AM BLOOD WBC-11.2* RBC-3.30* Hgb-10.0* Hct-29.6* MCV-90 MCH-30.4 MCHC-33.9 RDW-15.4 Plt Ct-283 [**2186-9-15**] 07:50PM BLOOD Glucose-100 UreaN-33* Creat-1.3* Na-135 K-3.4 Cl-99 HCO3-23 AnGap-16 [**2186-9-18**] 02:15AM BLOOD Glucose-69* UreaN-18 Creat-0.9 Na-138 K-3.4 Cl-105 HCO3-20* AnGap-16  CHEST (PORTABLE AP) Study Date of [**2186-9-15**] 7:39 PM 1.
Correlation with any prior imaging is recommended as findings suggest obstruction of the right sided collecting system; an ultrasound or CTU can be obtained for further evaluation.
CHEST (PORTABLE AP) Study Date of [**2186-9-18**] 4:11 AM Small right apical pneumothorax and small right pleural effusion have increased since [**9-17**] at 4:44 a.m.
Due to hypotension, he was bolused with LR and given albumin, and his SBP showed improvement from the 70s to the 90s.
His course was complicated by the patient's initial wishes to leave AMA and his refusal of an a-line, central line, and PICC.
Medications on Admission: -bicalutamide 50 mg Tablet -omeprazole 40 mg po qd -oxycodone 20 q12 -chemotherapy (unknown course, last treatment [**2186-7-7**])   Discharge Medications: 1. fentanyl 50 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr Transdermal Q72H (every 72 hours) as needed for esophageal cancer.
